3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.

Next Day Disclosure Return

Announcements and Notices - [Issue of Shares under a General Mandate]

Completion Of Placing Of New Shares
Under General Mandate

Announcements and Notices - [Placing / Issue of Shares under a General Mandate]

Placing Of New Shares Under General Mandate

Proposed Spin-Off And Separate Listing Of
Mandi Inc. On
The Main Board Of The Stock Exchange Of
Hong Kong Limited

Announcements and Notices - [Connected Transaction]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

3SBio Inc (1530 HK)

Next Day Disclosure Return

Completion Of Placing Of New Shares Under General Mandate

Placing Of New Shares Under General Mandate

Proposed Spin-Off And Separate Listing Of Mandi Inc. On The Main Board Of The Stock Exchange Of Hong Kong Limited

Connected Transaction Grant Of Awarded Shares By A Subsidiary Of The Company Pursuant To Its Equity Incentive Plan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)